![Jung-Jin Seo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jung-Jin Seo
Chairman at CELLTRION HEALTHCARE CO., LTD.
Net worth: 7 599 M $ as of 2024-06-29
Profile
Currently, Jung-Jin Seo occupies the position of Chairman at Celltrion Healthcare Co., Ltd., Chairman for Celltrion, Inc., Chairman for Celltrion Pharm Inc. (a subsidiary of Celltrion, Inc.) and Chief Executive Officer at Celltrion Holdings Co., Ltd. Mr. Seo is also on the board of Korea National Opera.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CELLTRION, INC.
27.65% | 2024-06-26 | 60,008,150 ( 27.65% ) | 7 599 M $ | 2024-06-29 |
Jung-Jin Seo active positions
Companies | Position | Start |
---|---|---|
CELLTRION HEALTHCARE CO., LTD. | Chairman | - |
CELLTRION PHARM, INC. | Chairman | 2009-01-22 |
CELLTRION, INC. | Chairman | - |
Korea National Opera
![]() Korea National Opera Movies/EntertainmentConsumer Services Korea National Opera presents live entertainment productions. Yong-Man Park has been the CEO of the South Korean company since 2016. | Director/Board Member | 2020-01-26 |
Former positions of Jung-Jin Seo
Companies | Position | End |
---|---|---|
Celltrion Holdings Co., Ltd.
![]() Celltrion Holdings Co., Ltd. Movies/EntertainmentConsumer Services Celltrion Holdings Co., Ltd. produces broadcast programs and offers system integration services. The company was founded on November 25, 2010 and is headquartered in Incheon, South Korea. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CELLTRION PHARM, INC. | Health Technology |
CELLTRION, INC. | Health Technology |
Private companies | 3 |
---|---|
Celltrion Healthcare Co., Ltd.
![]() Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Holdings Co., Ltd.
![]() Celltrion Holdings Co., Ltd. Movies/EntertainmentConsumer Services Celltrion Holdings Co., Ltd. produces broadcast programs and offers system integration services. The company was founded on November 25, 2010 and is headquartered in Incheon, South Korea. | Consumer Services |
Korea National Opera
![]() Korea National Opera Movies/EntertainmentConsumer Services Korea National Opera presents live entertainment productions. Yong-Man Park has been the CEO of the South Korean company since 2016. | Consumer Services |
- Stock Market
- Insiders
- Jung-Jin Seo